DaVita HealthCare Partners Inc (DVA): Today's Featured Health Services Laggard

DaVita HealthCare Partners ( DVA) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.4%. By the end of trading, DaVita HealthCare Partners fell $1.47 (-1.2%) to $120.80 on average volume. Throughout the day, 920,809 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 777,900 shares. The stock ranged in price between $120.11-$122.22 after having opened the day at $121.93 as compared to the previous trading day's close of $122.27. Other companies within the Health Services industry that declined today were: Pingtan Marine Enterprise ( PME), down 58.0%, IsoRay ( ISR), down 18.6%, LHC Group ( LHCG), down 13.1% and Gentiva Health Services ( GTIV), down 12.8%.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $12.9 billion and is part of the health care sector. The company has a P/E ratio of 31.1, above the S&P 500 P/E ratio of 17.7. Shares are up 10.6% year to date as of the close of trading on Thursday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the positive front, Stereotaxis ( STXS), up 10.7%, Baxano Surgical ( BAXS), up 10.1%, ZELTIQ Aesthetics ( ZLTQ), up 8.1% and Utah Medical Products ( UTMD), up 8.0% , were all gainers within the health services industry with Hologic ( HOLX) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

UnitedHealth Shares Jump on Fourth-Quarter Earnings Beat, Improved Guidance

UnitedHealth Shares Jump on Fourth-Quarter Earnings Beat, Improved Guidance

Are You Ready For a Correction?

Are You Ready For a Correction?

Aetna CEO to Receive $500 Million Once CVS Deal Closes: MARKETS LIVE

Aetna CEO to Receive $500 Million Once CVS Deal Closes: MARKETS LIVE

Dow and S&P 500 Decline, but Nasdaq Finishes Higher as Tech Recovers

Dow and S&P 500 Decline, but Nasdaq Finishes Higher as Tech Recovers

3 Things You Must Know About Wall Street as You Head to Lunch

3 Things You Must Know About Wall Street as You Head to Lunch